Hetty Carraway

Hetty Carraway, MD, MBA is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and a practicing hematologist-oncologist at the Cleveland Clinic. She serves as Director of the Leukemia Program and the Vice Chair of Strategy and Enterprise Development at the Taussig Cancer Institute at Cleveland Clinic. Dr. Carraway obtained her medical degree from the University of Massachusetts Medical School including a one year fellowship program in pathology. She then joined the Osler Medical Service and completed her training in Internal Medicine at Johns Hopkins University. After completing her Hematology-Oncology Fellowship at Johns Hopkins University, she joined the leukemia faculty until 2014 when she moved to Cleveland. In addition to her medical training, she earned an MBA from the Carey Business School at Johns Hopkins University in the Business of Health.

Her research interests focus on early phase clinical trials in the treatment of acute leukemias and myeloid neoplasms. Her early research interests began with investigation of DNA methylation in breast cancers and myeloid neoplasms and refining the tools to better test the methylation patterns using nanotechnology. Her interest in the use of combination epigenetic therapies with DNA hypomethylating agents and histone deacetylase inhibitors drove further interest to clinical management and investigation(s) for patients diagnosed with myeloid malignancies.

Dr. Carraway is an active member of numerous professional organizations including the American Society of Hematology (ASH) and serves as the Vice Chair on the Committee on Training at ASH. In this role, she works with ASH staff and other Heme-Onc Program Directors in the country to develop opportunities for education grant support and research infrastructure to improve the training for medical hematologists. Dr. Carraway was previously the Hem-Onc Fellowship Program Director at the Cleveland Clinic and is devoted to medical education for trainees; supporting a holistic approach to medicine from the basic pathogenesis of disease and extending to the “art” of medicine. Hematology is one of the most logical places in medicine to bridge these worlds.